GetPortalImpactFactorByIdResp(projectId=1, id=aed011790, cover=https://img.medsci.cn/20211022/1634873869020_1614372.jpg, fullname=Cancer Control, abbr=CANCER CONTROL, pyear=暂无数据, frequence=Quarterly, articleNumbers=976, citedSelf2015=0.4, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均5.55月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1073-2748, greenSci=https://www.greensci.net/search?kw=1073-2748, scijournal=https://www.scijournal.org/impact-factor-of-CANCER-CONTROL.shtml, medsciHotlightString=null, medsciHotlightRealtime=8.876, medsciHotlight=12.188, medsciHotlight5year=7.00606, citescore=3.4, hIndex=72, impactFactor=2.6, orgnization=H. Lee Moffitt Cancer Center and Research Institute, orgnizationUrl=https://journals.sagepub.com, country=United States, countryCn=美国, isOa=1, isOaString=是, sciScie=Science Citation Index Expanded, bigclassCas=医学 4区, smallclassCas=医学 3 区, website=https://journals.sagepub.com/home/ccxa?utm_source=Medsci&utm_medium=SAGE_social&utm_campaign=Medsci_CCX, websiteHits=7677, guideForAuthor=https://journals.sagepub.com/author-instructions/CCX?utm_source=Medsci&utm_medium=SAGE_social&utm_campaign=Medsci_CCX, guideForAuthorHits=656, submitWebsite=https://journals.sagepub.com/author-instructions/CCX?utm_source=Medsci&utm_medium=SAGE_social&utm_campaign=Medsci_CCX, submitWebsiteHits=4791, content=<p><em>Cancer Control </em>is a JCR-ranked open access journal whose mission is to advance the prevention, detection, diagnosis, treatment, and palliative care of cancer by enabling researchers, doctors, policymakers, and other healthcare professionals to freely share research along the cancer control continuum. Our vision is a world where gold-standard cancer care is the norm, not the exception.<br />The journal is organized into five topical sections, as well as a sixth curated by members of the Moffitt Cancer Center. The topical sections are inspired by the foci of the cancer control continuum (prevention, detection, diagnosis, treatment, survivorship).<br /><br /><strong>Article Types and Topics of Interest</strong> <br /><em>Cancer Control</em> welcomes original research (clinical studies), reviews, and commentaries. We encourage submissions relating to advances in the following areas:</p> <ul style="color: #000000;"> <li>Communications in cancer research</li> <li>Surveillance</li> <li>Social Determinants of Health Disparities</li> <li>Genetic Testing</li> <li>Decision-Making</li> <li>Dissemination of Evidence-Based Interventions</li> <li>Health Care Delivery and Quality of Care</li> <li>Epidemiology</li> <li>Measurement</li> </ul> <p>View a selection of the latest papers published in <em>Cancer Control</em>.</p> <p style="color: #333333;"><strong> Journal Highlights </strong></p> <ul> <li>Impact Factor of 1.990</li> <li>Published at SAGE since 2017</li> <li>Article Processing Charge of $2200 USD</li> <li>Focus on prevention, detection, diagnosis, treatment, and palliative care of cancer</li> <li>Fast and double-blind peer review by dedicated Associate Editors and Editorial Board Members</li> </ul> <p style="color: #333333;"><strong><em>Cancer Control </em></strong>is a JCR-ranked, peer-reviewed <span style="color: #006acc;">open access</span> journal whose mission is to advance the prevention, detection, diagnosis, treatment, and palliative care of cancer by enabling researchers, doctors, policymakers, and other healthcare professionals to freely share research along the cancer control continuum. Please see the Aims and Scope tab for further information.</p>, totalCites=2540, brief=CANCER CONTROL杂志医学行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=肿瘤学" >肿瘤学</a></strong>”子行业的级别不明杂志, articleType=绝大部分收录论著，也接收少量其它类型文章, medsciHeat=<span style="color: #000000;">黑</span>, medsciComment=杂志水平一般，也很冷门，关注人少，审稿周期可能也不一定快，如果文章质量不佳，或时间不紧的话，可以考虑考虑。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=aed011790'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=7), ImpactFactorTagDto(id=76, tagName=外科, createdHits=1), ImpactFactorTagDto(id=578, tagName=公共卫生, createdHits=1), ImpactFactorTagDto(id=38288, tagName=预防医学, createdHits=1), ImpactFactorTagDto(id=112012, tagName= 外科 , createdHits=1), ImpactFactorTagDto(id=111501, tagName= 肿瘤 , createdHits=1), ImpactFactorTagDto(id=313, tagName=临床, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=2.38), GetImpactFactorCiteScoreListResponse(year=2017, citescore=2.44), GetImpactFactorCiteScoreListResponse(year=2018, citescore=1.82), GetImpactFactorCiteScoreListResponse(year=2019, citescore=3.7), GetImpactFactorCiteScoreListResponse(year=2020, citescore=3.4)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=8.656), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=14.43), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=12.346), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=9.268), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=8.876)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Hematology , rank=57/122), GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Oncology , rank=199/321)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=ONCOLOGY, rank=Q3)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1073-2748[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=CANCER CONTROL[ta], article_number=154, article_number_cn=68, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)